TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs17667932
log Bayes Factor = 0.20904
Chromosome 8   position 118,549,376  (GRCh37) Explore rs17667932 on Ensembl!
Variant rs17667932 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M20 Acquired deformities of fingers and toes
0.000 0.621 0.379
M20.5 Other deformities of toe(s) (acquired)
0.000 0.622 0.378
M20.4 Other hammer toe(s) (acquired)
0.000 0.627 0.373
M20.1 Hallux valgus (acquired)
0.000 0.667 0.333
M20.0 Deformity of finger(s)
0.000 0.670 0.330
M20.3 Other deformity of hallux (acquired)
0.000 0.671 0.329
M20.2 Hallux rigidus
0.000 0.714 0.286
M20.6 Acquired deformity of toe(s), unspecified
0.000 0.729 0.271
Z87.1 Personal history of diseases of the digestive system
0.051 0.949 0.000
Z87.2 Personal history of diseases of the skin and subcutaneous tissue
0.038 0.962 0.000
Z87 Personal history of other diseases and conditions
0.036 0.964 0.000
Z87.3 Personal history of diseases of the musculoskeletal system and connective tissue
0.036 0.964 0.000
E10.9 Without complications
0.032 0.968 0.000
Z87.6 Personal history of certain conditions arising in the perinatal period
0.029 0.971 0.000
E10 Insulin-dependent diabetes mellitus
0.027 0.973 0.000
E10.4 With neurological complications
0.023 0.977 0.000
E10.3 With ophthalmic complications
0.023 0.977 0.000
Z87.5 Personal history of complications of pregnancy, childbirth and the puerperium
0.023 0.977 0.000
E10.5 With peripheral circulatory complications
0.022 0.977 0.000
E10.0 With coma
0.021 0.979 0.000
E10.2 With renal complications
0.021 0.979 0.000
E10.8 With unspecified complications
0.020 0.980 0.000
E10.7 With multiple complications
0.020 0.980 0.000
E10.6 With other specified complications
0.020 0.980 0.000
E10.1 With ketoacidosis
0.019 0.981 0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities
0.019 0.981 0.000
Z87.8 Personal history of other specified conditions
0.010 0.990 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.010 0.990 0.000
S22.00 Fracture of thoracic vertebra (closed)
0.010 0.990 0.000
S22.10 Multiple fractures of thoracic spine (closed)
0.010 0.990 0.000
S22 Fracture of rib(s), sternum and thoracic spine
0.010 0.990 0.000
S22.0 Fracture of thoracic vertebra
0.009 0.990 0.000
S22.1 Multiple fractures of thoracic spine
0.009 0.991 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.009 0.991 0.000
Z51.5 Palliative care
0.009 0.991 0.000
Y42.7 Androgens and anabolic congeners
0.009 0.991 0.000
Z87.0 Personal history of diseases of the respiratory system
0.009 0.991 0.000
E10-E14 Diabetes mellitus
0.009 0.991 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.009 0.991 0.000
Y42.5 Other oestrogens and progestogens
0.008 0.992 0.000
Y40 Systemic antibiotics
0.008 0.992 0.000
E87.6 Hypokalaemia
0.000 0.992 0.008
Y43 Primarily systemic agents
0.008 0.992 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.008 0.992 0.000
S22.4 Multiple fractures of ribs
0.008 0.992 0.000
S20-S29 Injuries to the thorax
0.008 0.992 0.000
Y40.9 Systemic antibiotic, unspecified
0.008 0.992 0.000
H18.5 Hereditary corneal dystrophies
0.008 0.992 0.000
S22.5 Flail chest
0.008 0.992 0.000
S27 Injury of other and unspecified intrathoracic organs
0.008 0.992 0.000
H18 Other disorders of cornea
0.008 0.992 0.000
Y52 Agents primarily affecting the cardiovascular system
0.008 0.992 0.000
Y42.9 Other and unspecified hormone antagonists
0.007 0.993 0.000
Y42.4 Oral contraceptives
0.007 0.993 0.000
Y42.2 Antithyroid drugs
0.007 0.993 0.000
Y42.1 Thyroid hormones and substitutes
0.007 0.993 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.007 0.993 0.000
S20 Superficial injury of thorax
0.007 0.993 0.000
Y43.4 Immunosuppressive agents
0.007 0.993 0.000
E13 Other specified diabetes mellitus
0.007 0.993 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.007 0.993 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
S22.9 Fracture of bony thorax, part unspecified
0.007 0.993 0.000
S22.8 Fracture of other parts of bony thorax
0.007 0.993 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.007 0.993 0.000
S22.01 Fracture of thoracic vertebra (open)
0.007 0.993 0.000
Y43.3 Other antineoplastic drugs
0.007 0.993 0.000
S22.11 Multiple fractures of thoracic spine (open)
0.007 0.993 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.007 0.993 0.000
H18.6 Keratoconus
0.007 0.993 0.000
S27.3 Other injuries of lung
0.007 0.993 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.007 0.993 0.000
S22.40 Multiple fractures of ribs (closed)
0.007 0.993 0.000
Y40.8 Other systemic antibiotics
0.007 0.993 0.000
S22.2 Fracture of sternum
0.007 0.993 0.000
E12 Malnutrition-related diabetes mellitus
0.006 0.993 0.000
S22.50 Flail chest (closed)
0.006 0.993 0.000
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.007 0.993 0.000
Y59 Other and unspecified vaccines and biological substances
0.006 0.993 0.000
Y58 Bacterial vaccines
0.006 0.993 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.006 0.993 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.006 0.993 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.006 0.993 0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.006 0.993 0.000
Y40.0 Penicillins
0.007 0.993 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.006 0.993 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.006 0.993 0.000
S27.1 Traumatic haemothorax
0.006 0.994 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.006 0.994 0.000
E11 Non-insulin-dependent diabetes mellitus
0.006 0.994 0.000
S20.2 Contusion of thorax
0.006 0.994 0.000
Y57 Other and unspecified drugs and medicaments
0.006 0.994 0.000
Y40.7 Antifungal antibiotics, systemically used
0.006 0.994 0.000
Y40.6 Rifamycins
0.006 0.994 0.000
Y40.5 Aminoglycosides
0.006 0.994 0.000
Y40.4 Tetracyclines
0.006 0.994 0.000
Y40.2 Chloramphenicol group
0.006 0.994 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.006 0.994 0.000
H18.1 Bullous keratopathy
0.006 0.994 0.000
S27.0 Traumatic pneumothorax
0.006 0.994 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.006 0.994 0.000
S27.2 Traumatic heamopneumothorax
0.006 0.994 0.000
Y46.6 Other and unspecified antiepileptics
0.006 0.994 0.000
Y48 Anaesthetics and therapeutic gases
0.006 0.994 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.006 0.994 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.006 0.994 0.000
E13.9 Without complications
0.006 0.994 0.000
S20.8 Superficial injuries of other and unspecified parts of thorax
0.006 0.994 0.000
Y43.9 Primarily systemic agent, unspecified
0.006 0.994 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.006 0.994 0.000
Y43.6 Enzymes, not elsewhere classified
0.006 0.994 0.000
Y43.5 Acidifying and alkalising agents
0.006 0.994 0.000
Y43.2 Antineoplastic natural products
0.006 0.994 0.000
H21 Other disorders of iris and ciliary body
0.006 0.994 0.000
S22.41 Multiple fractures of ribs (open)
0.006 0.994 0.000
H18.8 Other specified disorders of cornea
0.006 0.994 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.006 0.994 0.000
S28 Crushing injury of thorax and traumatic amputation of part of thorax
0.006 0.994 0.000
S26 Injury of heart
0.006 0.994 0.000
S25 Injury of blood vessels of thorax
0.006 0.994 0.000
S24 Injury of nerves and spinal cord at thorax level
0.006 0.994 0.000
S23 Dislocation, sprain and strain of joints and ligaments of thorax
0.006 0.994 0.000
S21 Open wound of thorax
0.006 0.994 0.000
H16 Keratitis
0.006 0.994 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.006 0.994 0.000
S22.51 Flail chest (open)
0.006 0.994 0.000
S27.9 Injury of unspecified intrathoracic organ
0.006 0.994 0.000
S27.8 Injury of other specified intrathoracic organs
0.006 0.994 0.000
S27.7 Multiple injuries of intrathoracic organs
0.006 0.994 0.000
S27.6 Injury of pleura
0.006 0.994 0.000
S27.5 Injury of thoracic trachea
0.006 0.994 0.000
S27.4 Injury of bronchus
0.006 0.994 0.000
E11.8 With unspecified complications
0.006 0.994 0.000
Y46.2 Hydantoin derivatives
0.006 0.994 0.000
Y40.3 Macrolides
0.006 0.994 0.000
S29 Other and unspecified injuries of thorax
0.006 0.994 0.000
Y43.0 Antiallergic and antiemetic drugs
0.006 0.994 0.000
H18.7 Other corneal deformities
0.006 0.994 0.000
H18.3 Changes in corneal membranes
0.006 0.994 0.000
H18.2 Other corneal oedema
0.006 0.994 0.000
H18.0 Corneal pigmentations and deposits
0.006 0.994 0.000
S20.3 Other superficial injuries of front wall of thorax
0.006 0.994 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.006 0.994 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.006 0.994 0.000
Y52.7 Peripheral vasodilators
0.006 0.994 0.000
Y52.1 Calcium-channel blockers
0.006 0.994 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.006 0.994 0.000
E11.6 With other specified complications
0.006 0.994 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.005 0.994 0.000
H20 Iridocyclitis
0.006 0.994 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.005 0.994 0.000
H21.5 Other adhesions and disruptions of iris and ciliary body
0.006 0.994 0.000
Y46.8 Antispasticity drugs
0.005 0.994 0.000
Y46.7 Anti-Parkinsonism drugs
0.005 0.994 0.000
Y46.5 Valproic acid
0.005 0.994 0.000
Y46.4 Iminostilbenes
0.005 0.994 0.000
Y46.3 Deoxybarbiturates
0.005 0.994 0.000
Y46.1 Oxazolidinediones
0.005 0.994 0.000
Y46.0 Succinimides
0.005 0.994 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.005 0.994 0.000
Y44 Agents primarily affecting blood constituents
0.005 0.994 0.000
H20.8 Other iridocyclitis
0.005 0.994 0.000
S20.7 Multiple superficial injuries of thorax
0.005 0.995 0.000
S20.4 Other superficial injuries of back wall of thorax
0.005 0.995 0.000
S20.1 Other and unspecified superficial injuries of breast
0.005 0.995 0.000
S20.0 Contusion of breast
0.005 0.995 0.000
H18.9 Disorder of cornea, unspecified
0.005 0.995 0.000
E13.8 With unspecified complications
0.005 0.995 0.000
E13.7 With multiple complications
0.005 0.995 0.000
E13.6 With other specified complications
0.005 0.995 0.000
E13.5 With peripheral circulatory complications
0.005 0.995 0.000
E13.4 With neurological complications
0.005 0.995 0.000
E13.3 With ophthalmic complications
0.005 0.995 0.000
E13.2 With renal complications
0.005 0.995 0.000
E13.1 With ketoacidosis
0.005 0.995 0.000
E13.0 With coma
0.005 0.995 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.005 0.995 0.000
Y45.8 Other analgesics and antipyretics
0.005 0.995 0.000
Y45.5 4-Aminophenol derivatives
0.005 0.995 0.000
Y45.4 Antirheumatics
0.005 0.995 0.000
S22.3 Fracture of rib
0.005 0.995 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.005 0.995 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
Y51.0 Anticholinesterase agents
0.005 0.995 0.000
S22.81 Fracture of other parts of bony thorax (open)
0.005 0.995 0.000
S22.80 Fracture of other parts of bony thorax (closed)
0.005 0.995 0.000
S22.91 Fracture of bony thorax, part unspecified (open)
0.005 0.995 0.000
S22.90 Fracture of bony thorax, part unspecified (closed)
0.005 0.995 0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)
0.005 0.995 0.000
Y43.1 Antineoplastic antimetabolites
0.005 0.995 0.000
E11.4 With neurological complications
0.005 0.995 0.000
S27.31 Other injuries of lung (with open wound into thoracic cavity)
0.005 0.995 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.005 0.995 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
Y53.7 Emetics
0.005 0.995 0.000
Y53.6 Antidiarrhoeal drugs
0.005 0.995 0.000
Y53.5 Digestants
0.005 0.995 0.000
Y53.4 Other laxatives
0.005 0.995 0.000
Y53.3 Saline and osmotic laxatives
0.005 0.995 0.000
Y53.2 Stimulant laxatives
0.005 0.995 0.000
Y53.0 Histamine H2-receptor antagonists
0.005 0.995 0.000
H16.4 Corneal neovascularisation
0.005 0.995 0.000
Y45.2 Propionic acid derivatives
0.005 0.995 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.995 0.000
M20-M25 Other joint disorders
0.000 0.995 0.005
Y49.5 Other antipsychotics and neuroleptics
0.005 0.995 0.000
H16.9 Keratitis, unspecified
0.005 0.995 0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)
0.005 0.995 0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)
0.005 0.995 0.000
E11.0 With coma
0.005 0.995 0.000
S22.21 Fracture of sternum (open)
0.005 0.995 0.000
E12.9 Without complications
0.005 0.995 0.000
E12.8 With unspecified complications
0.005 0.995 0.000
E12.7 With multiple complications
0.005 0.995 0.000
E12.6 With other specified complications
0.005 0.995 0.000
E12.5 With peripheral circulatory complications
0.005 0.995 0.000
E12.4 With neurological complications
0.005 0.995 0.000
E12.3 With ophthalmic complications
0.005 0.995 0.000
E12.2 With renal complications
0.005 0.995 0.000
E12.1 With ketoacidosis
0.005 0.995 0.000
E12.0 With coma
0.005 0.995 0.000
H18.4 Corneal degeneration
0.005 0.995 0.000
H21.0 Hyphaema
0.005 0.995 0.000
H17 Corneal scars and opacities
0.005 0.995 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.005 0.995 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.005 0.995 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.005 0.995 0.000
Y47.4 Bromine compounds
0.005 0.995 0.000
Y47.3 Paraldehyde
0.005 0.995 0.000
Y47.2 Chloral derivatives
0.005 0.995 0.000
Y47.1 Benzodiazepines
0.005 0.995 0.000
Y47.0 Barbiturates, not elsewhere classified
0.005 0.995 0.000
Y50.9 Central nervous system stimulant, unspecified
0.005 0.995 0.000
Y50.8 Other central nervous system stimulants
0.005 0.995 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.005 0.995 0.000
Y50.1 Opioid receptor antagonists
0.005 0.995 0.000
Y50.0 Analeptics
0.005 0.995 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.005 0.995 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.005 0.995 0.000
Y55.5 Anticommon cold drugs
0.005 0.995 0.000
Y55.4 Expectorants
0.005 0.995 0.000
Y55.3 Antitussives
0.005 0.995 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.005 0.995 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.005 0.995 0.000
Y55.0 Oxytocic drugs
0.005 0.995 0.000
Y58.9 Other and unspecified bacterial vaccines
0.005 0.995 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.005 0.995 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.005 0.995 0.000
Y58.5 Diphtheria vaccine
0.005 0.995 0.000
Y58.4 Tetanus vaccine
0.005 0.995 0.000
Y58.3 Plague vaccine
0.005 0.995 0.000
Y58.2 Cholera vaccine
0.005 0.995 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.005 0.995 0.000
Y58.0 BCG vaccine
0.005 0.995 0.000
Y59.9 Vaccine or biological substance, unspecified
0.005 0.995 0.000
Y59.8 Other specified vaccines and biological substances
0.005 0.995 0.000
Y59.3 Immunoglobulin
0.005 0.995 0.000
Y59.2 Protozoal vaccines
0.005 0.995 0.000
Y59.1 Rickettsial vaccines
0.005 0.995 0.000
Y59.0 Viral vaccines
0.005 0.995 0.000
H22 Disorders of iris and ciliary body in diseases classified elsewhere
0.005 0.995 0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere
0.005 0.995 0.000
H15 Disorders of sclera
0.005 0.995 0.000
Y49.9 Psychotropic drug, unspecified
0.005 0.995 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.005 0.995 0.000
Y49.7 Psychostimulants with abuse potential
0.005 0.995 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.005 0.995 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.005 0.995 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.005 0.995 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.005 0.995 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.005 0.995 0.000
Y45.0 Opioids and related analgesics
0.005 0.995 0.000
Y57.9 Drug or medicament, unspecified
0.005 0.995 0.000
M22 Disorders of patella
0.000 0.995 0.005
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)
0.005 0.995 0.000
E11.2 With renal complications
0.005 0.995 0.000
M22.8 Other disorders of patella
0.000 0.995 0.005
E11.7 With multiple complications
0.005 0.995 0.000
Y57.8 Other drugs and medicaments
0.005 0.995 0.000
Y57.7 Vitamins, not elsewhere classified
0.005 0.995 0.000
Y57.6 Other diagnostic agents
0.005 0.995 0.000
Y57.4 Pharmaceutical excipients
0.005 0.995 0.000
Y57.3 Alcohol deterrents
0.005 0.995 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.005 0.995 0.000
Y57.1 Lipotropic drugs
0.005 0.995 0.000
Y57.0 Appetite depressants [anorectics]
0.005 0.995 0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)
0.005 0.995 0.000
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)
0.005 0.995 0.000
Y48.5 Therapeutic gases
0.004 0.995 0.000
Y48.4 Anaesthetic, unspecified
0.004 0.995 0.000
Y48.2 Other and unspecified general anaesthetics
0.004 0.995 0.000
Y48.1 Parenteral anaesthetics
0.004 0.995 0.000
Y48.0 Inhaled anaesthetics
0.004 0.995 0.000
Y49.2 Other and unspecified antidepressants
0.004 0.995 0.000
Y56.9 Topical agent, unspecified
0.004 0.995 0.000
Y56.8 Other topical agents
0.004 0.995 0.000
Y56.7 Dental drugs, topically applied
0.004 0.995 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.004 0.995 0.000
Y56.5 Ophthalmological drugs and preparations
0.004 0.995 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.004 0.995 0.000
Y56.3 Emollients, demulcents and protectants
0.004 0.995 0.000
Y56.2 Local astringents and local detergents
0.004 0.995 0.000
Y56.1 Antipruritics
0.004 0.995 0.000
S22.20 Fracture of sternum (closed)
0.004 0.995 0.000
H21.9 Disorder of iris and ciliary body, unspecified
0.004 0.995 0.000
H21.4 Pupillary membranes
0.004 0.995 0.000
H21.3 Cyst of iris, ciliary body and anterior chamber
0.004 0.995 0.000
H21.2 Degeneration of iris and ciliary body
0.004 0.995 0.000
H21.1 Other vascular disorders of iris and ciliary body
0.004 0.995 0.000
S21.9 Open wound of thorax, part unspecified
0.004 0.995 0.000
S21.8 Open wound of other parts of thorax
0.004 0.995 0.000
S21.7 Multiple open wounds of thoracic wall
0.004 0.995 0.000
S21.2 Open wound of back wall of thorax
0.004 0.995 0.000
S21.1 Open wound of front wall of thorax
0.004 0.995 0.000
S21.0 Open wound of breast
0.004 0.995 0.000
S23.5 Sprain and strain of other and unspecified parts of thorax
0.004 0.995 0.000
S23.4 Sprain and strain of ribs and sternum
0.004 0.995 0.000
S23.3 Sprain and strain of thoracic spine
0.004 0.995 0.000
S23.2 Dislocation of other and unspecified parts of thorax
0.004 0.995 0.000
S23.1 Dislocation of thoracic vertebra
0.004 0.995 0.000
S23.0 Traumatic rupture of thoracic intervertebral disk
0.004 0.995 0.000
S24.6 Injury of unspecified nerve of thorax
0.004 0.995 0.000
S24.5 Injury of other nerves of thorax
0.004 0.995 0.000
S24.4 Injury of thoracic sympathetic nerves
0.004 0.995 0.000
S24.3 Injury of peripheral nerves of thorax
0.004 0.995 0.000
S24.2 Injury of nerve root of thoracic spine
0.004 0.995 0.000
S24.1 Other and unspecified injuries of thoracic spinal cord
0.004 0.995 0.000
S24.0 Concussion and oedema of thoracic spinal cord
0.004 0.995 0.000
S25.9 Injury of unspecified blood vessel of thorax
0.004 0.995 0.000
S25.8 Injury of other blood vessels of thorax
0.004 0.995 0.000
S25.7 Injury of multiple blood vessels of thorax
0.004 0.995 0.000
S25.5 Injury of intercostal blood vessels
0.004 0.995 0.000
S25.4 Injury of pulmonary blood vessels
0.004 0.995 0.000
S25.3 Injury of innominate or subclavian vein
0.004 0.995 0.000
S25.2 Injury of superior vena cava
0.004 0.995 0.000
S25.1 Injury of innominate or subclavian artery
0.004 0.995 0.000
S25.0 Injury of thoracic aorta
0.004 0.995 0.000
S26.9 Injury of heart, unspecified
0.004 0.995 0.000
S26.8 Other injuries of heart
0.004 0.995 0.000
S26.0 Injury of heart with haemopericardium
0.004 0.995 0.000
S28.1 Traumatic amputation of part of thorax
0.004 0.995 0.000
S28.0 Crushed chest
0.004 0.995 0.000
H16.8 Other keratitis
0.004 0.995 0.000
H16.3 Interstitial and deep keratitis
0.004 0.995 0.000
H16.2 Keratoconjunctivitis
0.004 0.995 0.000
H16.1 Other superficial keratitis without conjunctivitis
0.004 0.995 0.000
Y54.9 Mineral salts, not elsewhere classified
0.004 0.995 0.000
Y54.8 Agents affecting uric acid metabolism
0.004 0.995 0.000
Y54.7 Agents affecting calcification
0.004 0.995 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.004 0.995 0.000
Y54.4 Loop [high-ceiling] diuretics
0.004 0.995 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.004 0.995 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.004 0.995 0.000
Y54.0 Mineralocorticoids
0.004 0.995 0.000
H54.7 Unspecified visual loss
0.005 0.995 0.000
M34 Systemic sclerosis
0.000 0.995 0.004
S27.41 Injury of bronchus (with open wound into thoracic cavity)
0.004 0.996 0.000
S27.40 Injury of bronchus (without open wound into thoracic cavity)
0.004 0.996 0.000
S27.51 Injury of thoracic trachea (with open wound into thoracic cavity)
0.004 0.996 0.000
S27.50 Injury of thoracic trachea (without open wound into thoracic cavity)
0.004 0.996 0.000
S27.61 Injury of pleura (with open wound into thoracic cavity)
0.004 0.996 0.000
S27.60 Injury of pleura (without open wound into thoracic cavity)
0.004 0.996 0.000
S27.71 Multiple injuries of intrathoracic organs (with open wound into thoracic cavity)
0.004 0.996 0.000
S27.70 Multiple injuries of intrathoracic organs (without open wound into thoracic cavity)
0.004 0.996 0.000
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)
0.004 0.996 0.000
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)
0.004 0.996 0.000
S27.91 Injury of unspecified intrathoracic organ (with open wound into thoracic cavity)
0.004 0.996 0.000
S27.90 Injury of unspecified intrathoracic organ (without open wound into thoracic cavity)
0.004 0.996 0.000
Y54.5 Other diuretics
0.004 0.996 0.000
S29.8 Other specified injuries of thorax
0.004 0.996 0.000
S29.7 Multiple injuries of thorax
0.004 0.996 0.000
S29.0 Injury of muscle and tendon at thorax level
0.004 0.996 0.000
Y48.3 Local anaesthetics
0.004 0.996 0.000
H20.2 Lens-induced iridocyclitis
0.004 0.996 0.000
H20.1 Chronic iridocyclitis
0.004 0.996 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.004 0.996 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.004 0.996 0.000
Y41.5 Antiviral drugs
0.004 0.996 0.000
Y41.4 Anthelminthics
0.004 0.996 0.000
Y41.3 Other antiprotozoal drugs
0.004 0.996 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.004 0.996 0.000
Y41.1 Antimycobacterial drugs
0.004 0.996 0.000
Y41.0 Sulphonamides
0.004 0.996 0.000
H16.0 Corneal ulcer
0.004 0.996 0.000
H20.0 Acute and subacute iridocyclitis
0.004 0.996 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.004 0.996 0.000
Y44.7 Plasma substitutes
0.004 0.996 0.000
Y44.6 Natural blood and blood products
0.004 0.996 0.000
Y44.5 Thrombolytic drugs
0.004 0.996 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.004 0.996 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.004 0.996 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.004 0.996 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.004 0.996 0.000
Y57.5 X-ray contrast media
0.004 0.996 0.000
Y45.1 Salicylates
0.004 0.996 0.000
S29.9 Unspecified injury of thorax
0.004 0.996 0.000
S22.31 Fracture of rib (open)
0.004 0.996 0.000
H21.8 Other specified disorders of iris and ciliary body
0.004 0.996 0.000
H54.4 Blindness, one eye
0.004 0.996 0.000
M22.2 Patellofemoral disorders
0.000 0.996 0.004
H54 Blindness and low vision
0.004 0.996 0.000
M36 Systemic disorders of connective tissue in diseases classified elsewhere
0.000 0.996 0.004
Y54.3 Benzothiadiazine derivatives
0.004 0.996 0.000
E11.5 With peripheral circulatory complications
0.004 0.996 0.000
H15.9 Disorder of sclera, unspecified
0.004 0.996 0.000
H15.8 Other disorders of sclera
0.004 0.996 0.000
H15.1 Episcleritis
0.004 0.996 0.000
H15.0 Scleritis
0.004 0.996 0.000
H17.9 Corneal scar and opacity, unspecified
0.004 0.996 0.000
H17.8 Other corneal scars and opacities
0.004 0.996 0.000
H17.1 Other central corneal opacity
0.004 0.996 0.000
H17.0 Adherent leukoma
0.004 0.996 0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere
0.004 0.996 0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere
0.004 0.996 0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
0.004 0.996 0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.004 0.996 0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere
0.004 0.996 0.000
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere
0.004 0.996 0.000
H22.1 Iridocyclitis in other diseases classified elsewhere
0.004 0.996 0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere
0.004 0.996 0.000
M34.9 Systemic sclerosis, unspecified
0.000 0.996 0.004
M22.1 Recurrent subluxation of patella
0.000 0.996 0.004
M22.9 Disorder of patella, unspecified
0.000 0.996 0.004
M22.0 Recurrent dislocation of patella
0.000 0.996 0.004
Q87.4 Marfan's syndrome
0.004 0.996 0.000
M21 Other acquired deformities of limbs
0.000 0.996 0.004
M30 Polyarteritis nodosa and related conditions
0.000 0.996 0.004
M34.1 CR(E)ST syndrome
0.000 0.996 0.004
E14 Unspecified diabetes mellitus
0.004 0.996 0.000
M32 Systemic lupus erythematosus
0.000 0.996 0.004
M22.4 Chondromalacia patellae
0.000 0.996 0.004
Z95.8 Presence of other cardiac and vascular implants and grafts
0.004 0.996 0.000
M33 Dermatopolymyositis
0.000 0.996 0.003
M22.3 Other derangements of patella
0.000 0.996 0.003
H43.9 Disorder of vitreous body, unspecified
0.004 0.996 0.000
S26.01 Injury of heart with haemopericardium (with open wound into thoracic cavity)
0.003 0.996 0.000
S26.00 Injury of heart with haemopericardium (without open wound into thoracic cavity)
0.003 0.996 0.000
S26.81 Other injuries of heart (with open wound into thoracic cavity)
0.003 0.996 0.000
S26.80 Other injuries of heart (without open wound into thoracic cavity)
0.003 0.996 0.000
S26.91 Injury of heart, unspecified (with open wound into thoracic cavity)
0.003 0.996 0.000
S26.90 Injury of heart, unspecified (without open wound into thoracic cavity)
0.003 0.996 0.000
E11.1 With ketoacidosis
0.003 0.996 0.000
E11.3 With ophthalmic complications
0.003 0.996 0.000
M34.8 Other forms of systemic sclerosis
0.000 0.996 0.003
M34.2 Systemic sclerosis induced by drugs and chemicals
0.000 0.996 0.003
M34.0 Progressive systemic sclerosis
0.000 0.996 0.003
H54.9 Unspecified visual impairment (binocular)
0.003 0.997 0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems
0.003 0.997 0.000
K86.0 Alcohol-induced chronic pancreatitis
0.003 0.997 0.000
M21.0 Valgus deformity, not elsewhere classified
0.000 0.997 0.003
H20.9 Iridocyclitis, unspecified
0.003 0.997 0.000
H54.0 Blindness, both eyes
0.003 0.997 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.003 0.997 0.000
H54.6 Unqualified visual loss, one eye
0.003 0.997 0.000
H54.5 Low vision, one eye
0.003 0.997 0.000
H54.3 Unqualified visual loss, both eyes
0.003 0.997 0.000
H54.2 Low vision, both eyes
0.003 0.997 0.000
H54.1 Blindness, one eye, low vision, other eye
0.003 0.997 0.000
Y44.2 Anticoagulants
0.003 0.997 0.000
H43 Disorders of vitreous body
0.003 0.997 0.000
M47.96 Spondylosis, unspecified (Lumbar region)
0.003 0.997 0.000
M36.8 Systemic disorders of connective tissue in other diseases classified elsewhere
0.000 0.997 0.003
M36.4 Arthropathy in hypersensitivity reactions classified elsewhere
0.000 0.997 0.003
M36.3 Arthropathy in other blood disorders
0.000 0.997 0.003
M36.2 Haemophilic arthropathy
0.000 0.997 0.003
M36.1 Arthropathy in neoplastic disease
0.000 0.997 0.003
M36.0 Dermato(poly)myositis in neoplastic disease
0.000 0.997 0.003
Z96.0 Presence of urogenital implants
0.000 0.997 0.003
Q80-Q89 Other congenital malformations
0.003 0.997 0.000
H43.3 Other vitreous opacities
0.003 0.997 0.000
M21.06 Valgus deformity, not elsewhere classified (Lower leg)
0.000 0.997 0.003
M47.99 Spondylosis, unspecified (Site unspecified)
0.003 0.997 0.000
M21.1 Varus deformity, not elsewhere classified
0.000 0.997 0.003
M22.10 Recurrent subluxation of patella, unspecified knee
0.000 0.997 0.003
Q82 Other congenital malformations of skin
0.003 0.997 0.000
Q82.8 Other specified congenital malformations of skin
0.003 0.997 0.000
H43.1 Vitreous haemorrhage
0.003 0.997 0.000
M21.9 Acquired deformity of limb, unspecified
0.000 0.997 0.003
M21.8 Other specified acquired deformities of limbs
0.000 0.997 0.003
M21.7 Unequal limb length (acquired)
0.000 0.997 0.003
M21.6 Other acquired deformities of ankle and foot
0.000 0.997 0.003
M21.5 Acquired clawhand, clubhand, clawfoot and clubfoot
0.000 0.997 0.003
M30.8 Other conditions related to polyarteritis nodosa
0.000 0.997 0.003
M30.3 Mucocutaneous lymph node syndrome [Kawasaki]
0.000 0.997 0.003
M30.2 Juvenile polyarteritis
0.000 0.997 0.003
M30.0 Polyarteritis nodosa
0.000 0.997 0.003
E14.8 With unspecified complications
0.003 0.997 0.000
E14.7 With multiple complications
0.003 0.997 0.000
E14.6 With other specified complications
0.003 0.997 0.000
E14.5 With peripheral circulatory complications
0.003 0.997 0.000
E14.4 With neurological complications
0.003 0.997 0.000
E14.2 Withrenal complications
0.003 0.997 0.000
E14.1 With ketoacidosis
0.003 0.997 0.000
E14.0 With coma
0.003 0.997 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.